Maze House Medical

Maze House Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Maze House Medical is a specialized, founder-led medical writing services firm catering to the regulatory documentation needs of pharmaceutical companies, CROs, and academia. With deep expertise across all phases of drug development, the company's core value proposition is delivering complex regulatory documents with high quality, clarity, and adherence to tight deadlines. Its business model is built on long-term client partnerships, leveraging the extensive industry experience of its founder, Duncan J Currie, who has held senior medical writing roles at major organizations like Pfizer, PPD, and Chiltern.

Medical DevicesDiagnostics

Technology Platform

Service-based expertise in regulatory medical writing and document preparation, following ICH guidelines and client SOPs.

Opportunities

The growing outsourcing trend in pharma R&D and the constant need for compliant regulatory submissions create steady demand for expert medical writing services.
A strong reputation can lead to repeat business and referrals within a niche network of sponsors and CROs.

Risk Factors

The business is entirely dependent on its founder (key person risk).
It faces competition from both individual freelancers and large CROs, and its revenue is susceptible to fluctuations in client project pipelines and broader pharmaceutical R&D spending.

Competitive Landscape

Maze House Medical competes in a fragmented market including large global Contract Research Organizations (CROs) with dedicated writing departments, specialized medical writing agencies, and numerous independent freelance medical writers. Its differentiation is the direct, senior-level expertise of its founder with a proven track record at major pharmaceutical companies.